Business
OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio
MIDDLETOWN, Pa., September 03, 2025--OpZira, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation.
About this update from Alcon Ag
MIDDLETOWN, Pa., September 03, 2025 --( BUSINESS WIRE )--OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera ( https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/ ) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: "Building on the LumiThera team’s success in developing the Valeda treatment for early to intermediate dry AMD patients, the OpZira technologies may provide early detection and ongoing monitoring which are important for optimizing patient outcomes," stated Eleonora Lad, MD, PhD, Duke University Medical Center. "Now that there are approved treatment options for dry AMD, having tools that provide objective data to help determine when and how often to treat patients is critical." "OpZira was founded to bridge the gap between groundbreaking research and practical clinical tools," said Clark Tedford, PhD, President & CEO of OpZira. "Our mission is to give eye care professionals the technology they need to detect ocular diseases earlier and monitor them more effectively." About OpZira OpZira, Inc. is a forward-thinking ophthalmic medical device company founded on a legacy of research excellence. The company delivers innovative technologies designed to enhance the detection and monitoring of ocular disease. For more information, visit OpZira.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20250903785229/en/ Contacts [email protected]